Havrix 1440, susp inj 1 ml (ancien), ser prê 1 dos
7680005580054
CH-558
J07BC02
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
VACC
|
1440.0 U | Substance | Wirkstoff (Principe actif) |
|
VACC
|
- | Substance | WIZUS |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
0.5 MG | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
166.0 UG | Substance | HBESI |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HBESI |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 558
- Drug name
- Havrix 1440, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/09/1993
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HAVRIX 1440 susp inj ser pré 1 ml
- Description (DE)
- HAVRIX 1440 Inj Susp Fertspr 1 ml
- Narcotic (BTM)
- No
Application methods
IMU